Anti-Diabetic Pharmaceuticals Market in India 2012 Published : March 2012 Price:Single User-US$600
No. of Pages : 76 Corporate User-US$1200
Anti-diabetic pharmaceuticals market in India is one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world after China, the Indian market is characterized by a huge demand for anti-diabetic drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of diabetes cases, introduction of newer and better drugs, increasing aging population and introduction of diabetes insurance policies is helping the market to grow. The Indian Government, on its part, has introduced some diabetes control programmes. The market is expected to exhibit steady growth over the next few years. The report begins with the introduction section which offers a brief classification of the different types of diabetes. It then gives a classification of the diabetes market, and then provides a brief description of different classes of anti-diabetic pharmaceuticals. The market overview section provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. It also provides a global diabetes map. A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals for anti-diabetic drugs. The competition section gives overview of pharmaceutical companies in the country operating in the anti diabetic pharmaceutical and insulin segments along with segmentation of players in respect to production of oral drugs and insulin. Thereafter, the report highlights the features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporated for a brief but effective understanding of the market scenario. Indian Anti-diabetic Pharmaceuticals Market Table Of contents Executive summary Introduction Types of diabetes Classification of the diabetes market Classes of anti-diabetic drugs Market Overview Global Anti-Diabetic Pharmaceuticals Market â€“ Overview, Size & Growth (Value: 2010-15e), Indian Anti-Diabetic Pharmaceuticals Market- Overview, Size & Growth (Value: 2010-2015e), Growth in Therapeutic segments Global Diabetes map Drivers & Challenges Summary Drivers Page13-14: Challenges Government initiatives Government programmes Market Value Chain, Regulation and Patents Pharmaceutical value chain Page17: Phases of clinical trials
Page18-19: Drug regulations Regulatory framework List of patent approvals Competition Competition overview Segmentation of players Market Competition – Porter’s Five Forces Analysis Summary- Major public players Major Public Players Aventis Pharma Limited Biocon Limited Cipla Limited Dr. Reddy's Laboratories Limited GlaxoSmithKline Pharmaceuticals Limited Merck Limited Panacea Biotec Limited Ranbaxy Laboratories Limited Strides Arcolab Limited Sun Pharmaceutical Industries Limited Torrent Pharmaceuticals Limited Wockhardt Limited Summary – Major Private Players Major Private Players Bristol-Myers Squibb India Private Limited Eli Lilly and Company (India) Private Limited Novo Nordisk India Private Limited Takeda Pharmaceuticals India Private Limited Recent Developments Strategic Recommendation Strategic Recommendations List of Tables List of Charts & Figures
Published on Apr 3, 2012
Published on Apr 3, 2012
Anti-diabetic pharmaceuticals market in India is one of the most lucrative diabetes markets in the world. Since India is the second largest...